Woodward heads into its May 4 Q2 2026 earnings release with a rare alignment of analyst conviction and a stock trading at a meaningful discount to consensus targets.
The analyst setup is the standout here. UBS raised its price target to $429 on April 30 — the day before earnings week — while maintaining a Buy rating. RBC Capital initiated coverage at Outperform with a $450 target on April 17, and Wells Fargo launched at Overweight with a $440 target on April 1. That's three fresh positive initiations or target lifts from substantive names inside the past 30 days. The consensus mean target now runs at $433.70, roughly 19% above Thursday's close of $362.99. Analyst recommendation disparity ranks in the 98th percentile — a near-record spread between where the stock trades and where the Street thinks it should be.
The short data offers no meaningful pushback on that bullish read. Short interest is a slim 1.1% of the free float — barely a rounding error for an aerospace components maker of this size. Shorts actually pulled back sharply over the past week, with estimated shares short falling nearly 13%. Borrowing costs are negligible at 0.42% annualised, and availability in the lending market is extremely loose, with virtually no squeeze pressure of any kind. The ORTEX short score of 27.8 reflects the same picture: this is not a heavily contested name. Options positioning tells a similarly relaxed story. The put/call ratio has eased to 0.62, well below its 20-day average of 0.74, with the z-score at -1.2 — options traders are actually tilting toward calls, not hedging for a downside miss.
The bull case rests squarely on earnings momentum and execution quality. EPS surprise ranks in the 83rd percentile, and 90-day forward EPS momentum sits in the 78th percentile — both pointing to a company that has consistently beaten expectations and drawn upward estimate revisions. The February 2026 quarterly print validated this: the stock jumped 16.8% the following day and extended gains to 23.6% over the next five sessions. The bear case is thinner but real. The PE of 38.9x and EV/EBITDA near 24.6x represent premium aerospace valuations. One Hold-rated analyst (TD Cowen, target $390) sits below consensus, pointing to valuation discipline rather than fundamental concern. The CEO sold just over $2.2 million worth of shares across multiple tranches in early March — a modest but notable reduction from a key insider — though at significance scores of just 2 out of 10, the trades read more like routine housekeeping than a strong signal.
The May 4 print will test whether Woodward's execution in aerospace and industrial energy systems can sustain the premium multiple that analysts have been willing to grant — and whether the three fresh initiations from April were well-timed or premature.
See the live data behind this article on ORTEX.
Open WWD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
